Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Pohlman patent opposition analysis

Law FirmOpposition Filing Analysis

The comprehensive analysis of Pohlman opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Pohlman

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3630946	Cell Culture Methods	UCB BIOPHARMA	Dec 23, 2024	POHLMAN
EP3530670	Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding Same	SEIKAGAKU	Nov 22, 2024	POHLMAN
EP4219687	Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive Therapy	JUNO THERAPEUTICS	Oct 29, 2024	POHLMAN
EP3384049	Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-Vegf	REGENERON PHARMACEUTICALS	Apr 30, 2024	POHLMAN
EP3911354	Aav-Mediated Gene Therapy Restoring The Otoferlin Gene	INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE	Apr 19, 2024	POHLMAN
EP3230316	Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization Lesion	BAYER HEALTHCARE	Oct 4, 2022	WITHERS & ROGERS
EP3464373	Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer	BRISTOL MYERS SQUIBB	Jul 26, 2022	POHLMAN
EP3498734	Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer	PFIZER	May 31, 2022	POHLMAN
EP3401335	Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof	GENENTECH	Mar 22, 2022	POHLMAN
EP3288980	Treatment Of Pd-L1-Positive Melanoma Using An Anti-Pd-1 Antibody	BRISTOL MYERS SQUIBB	Dec 10, 2021	POHLMAN

Top companies who are the clients of Pohlman

Company	Total
POHLMAN	27
FOUNDATION MEDICINE	4
ALKERMES PHARMA IRELAND	1
DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBB	1
GRUND	1
WITHERS & ROGERS	1